NTLA
#2075
Intellia Therapeutics, Inc. - Common Stock
13.1 1 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.61%
Monthly Change
+21.73%
6 month change
-5.03%
Year Change
-4.45%
Previous Close
13.1 9
Open
13.1 1
Low
13.1 1
High
13.1 1
Volume
210
Financials
- Market Capitalization 1.84 B
- Employee 377
- Founded 2014
- CEO John Leonard
- Website www.intelliatx.com
- Headquarter Delaware, United States
- FIGI BBG007KC7PB0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.36
Price to sales ratio
14.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2056 |  SEPN Septerna, Inc. - Common Stock | 40.47 USD | +0.55% | -2.34% | +19.13% | +83.87% | 1.89 B USD | ||
| 2073 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.44 USD | -1.43% | 0.00% | +13.53% | -29.07% | 1.84 B USD | ||
| 2079 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 123.93 USD | -1.12% | +23.00% | +55.05% | +53.80% | 1.82 B USD | ||
| 2083 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.16 USD | +0.35% | +1.15% | +2.13% | +23.08% | 1.80 B USD |
Frequently asked questions about Intellia Therapeutics, Inc
What is the Intellia Therapeutics, Inc stock price today?
The current price of Intellia Therapeutics, Inc (NTLA) is 13.11. Over the past 24 hours, the stock has changed by -0.61%. Follow the NTLA chart for real-time price dynamics.
What is the stock ticker of Intellia Therapeutics, Inc?
Intellia Therapeutics, Inc trades under the ticker NTLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Intellia Therapeutics, Inc stock going up?
NTLA has changed by +3.64% over the last week, +21.73% over the last month, and -4.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Intellia Therapeutics, Inc?
Intellia Therapeutics, Inc currently has a market capitalization of 1.84 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Intellia Therapeutics, Inc earnings last quarter?
Last quarter, Intellia Therapeutics, Inc reported earnings of -0.8 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Intellia Therapeutics, Inc revenue for the last quarter?
Intellia Therapeutics, Inc reported quarterly revenue of 7.66 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Intellia Therapeutics, Inc net income for the last quarter?
Intellia Therapeutics, Inc reported net income of -106.63 M for the last quarter. The previous quarter showed -96.23 M, which means net income changed by -10.81%.
How many employees does Intellia Therapeutics, Inc have?
As of the latest available data, Intellia Therapeutics, Inc has 377 employees. Workforce size can provide additional context about the company's scale and operations.
What is Intellia Therapeutics, Inc EBITDA?
Intellia Therapeutics, Inc EBITDA is -110.66 M, and its EBITDA margin is -1 444.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Intellia Therapeutics, Inc stock?
You can buy Intellia Therapeutics, Inc (NTLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Intellia Therapeutics, Inc stock?
Investing in Intellia Therapeutics, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NTLA chart and related analysis on metatrader.com as part of your research.